You need to enable JavaScript to run this app.
FDA offers guidance on development of antimicrobials for diabetic foot infections
Regulatory News
Michele G. Sullivan
Chemistry, Manufacturing and Controls (CMC)
North America
Pharmaceuticals
Quality Assurance and Control
Regulatory Intelligence/Policy